Andrew D. Leavitt, MD

Professor and Medical Director
Adult Hemophilia Treatment Center, University of California San Francisco
San Francisco, California, United States

Andrew D. Leavitt, MD. Professor of Medicine and Laboratory Medicine, University of California San Francico (UCSF), USA. Dr. Leavitt received his MD degree from Harvard Medical School, completed his internal medicine training at the University of Michigan (Ann Arbor), and completed his hematology and transfusion medicine fellowships at the University of California San Francisco. He is currently the medical director of adult non-malignant (classical) hematology at UCSF, and the medical director of the UCSF Adult Hemophilia Treatment Center.

Presentation(s):

• OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1

  Monday, June 24, 2024
  09:45 – 10:00 ICT

• OC 30.3 - Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec

  Monday, June 24, 2024
  10:00 – 10:15 ICT